April 29, 2016 10:56 AM ET


Company Overview of Nucleonics, Inc.

Company Overview

Nucleonics, Inc. develops RNAi therapeutics for viral and other diseases. It offers NUC-B1000, a hepatitis B antiviral agent. The company also focuses on the development of eiRNA-based therapeutics for chronic hepatitis B and hepatitis C infections. Nucleonics, Inc. was founded in 2001 and is based in Langhorne, Pennsylvania.

13 Summit Square Center

Suite 305

Langhorne, PA 19047-1098

United States

Founded in 2001





Key Executives for Nucleonics, Inc.

Chief Medical Officer
Age: 75
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Kepley Biosystems Incorporated United States
Hyperion Therapeutics, Inc. United States
Evotec (US), Inc. United States
SironRX Therapeutics, Inc. United States
ProGDerm Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nucleonics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.